Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
1	1 BioXcel Therapeutics BTAI $48.2M	786% upside 3 price targets	0
2	2 Plus Therapeutics PSTV $42.8M	751% upside 3 price targets	0
3	3 Iovance Biotherapeutics IOVA $796M	718% upside 3 price targets	0
4	4 Passage Bio PASG $24M	685% upside 4 price targets	0
5	5 Context Therapeutics CNTX $89.7M	450% upside 4 price targets	0
6	6 Clene CLNN $63.4M	438% upside 3 price targets	0
7	7 Cardiff Oncology CRDF $144M	402% upside 3 price targets	0
8	8 Humacyte HUMA $284M	389% upside 4 price targets	0
9	9 Cabaletta Bio CABA $199M	382% upside 4 price targets	0
10	10 Compass Therapeutics CMPX $631M	380% upside 3 price targets	0
11	11 Metagenomi MGX $80.3M	367% upside 3 price targets	0
12	12 Larimar Therapeutics LRMR $366M	360% upside 3 price targets	0
13	13 Biomea Fusion BMEA $124M	357% upside 4 price targets	0
14	14 Zura Bio ZURA $133M	355% upside 3 price targets	0
15	15 Gain Therapeutics GANX $61.1M	351% upside 3 price targets	0
16	16 Cullinan Oncology CGEM $375M	342% upside 3 price targets	0
17	17 Astria Therapeutics ATXS $422M	323% upside 3 price targets	0
18	18 Sagimet Biosciences SGMT $220M	320% upside 3 price targets	0
19	CMPS 19 Compass Pathways CMPS $487M	300% upside 3 price targets	0
20	ALMS 20 Alumis Inc. Common Stock ALMS $446M	290% upside 4 price targets	0
21	21 Regenxbio RGNX $473M	274% upside 4 price targets	0
22	MBX 22 MBX Biosciences, Inc. Common Stock MBX $338M	271% upside 3 price targets	0
23	ADAG 23 Adagene ADAG $97.6M	270% upside 3 price targets	0
24	IVA 24 Inventiva IVA $754M	263% upside 3 price targets	0
25	25 Relay Therapeutics RLAY $784M	252% upside 3 price targets	0